Status:
UNKNOWN
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial
Lead Sponsor:
Medipost Co Ltd.
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
19+ years
Phase:
PHASE1
Brief Summary
This is a follow-up study to investigate the long-term safety and explore efficacy of SMUP-IA-01, for the treatment of Knee Osteoarthritis. Subjects who participated in and completed the initial stage...
Detailed Description
The subjects will be followed up at 6-month, 12-month, 24-month, 36-month, 48-month and 60-month after the initial administration of SMUP-IA-01.
Eligibility Criteria
Inclusion
- Subject who completed the safety and explore efficacy evaluations in SMUP-IA-01 Phase I clinical trial.
- Subjects who have been treated with either SMUP-IA-01 at least 6 months ago.
- Subjects who voluntarily decided to participate and signed the consent form after receiving explanations on the clinical trial.
Exclusion
- Subjects who were not enrolled in phase 1 clinical trial of SMUP-IA-01 for assessing safety and explore efficacy.
- Other subjects, excluding those listed above, who were deemed unsuitable by the PI
Key Trial Info
Start Date :
April 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04339504
Start Date
April 14 2020
End Date
December 1 2025
Last Update
March 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul national University Hospital
Seoul, Jongno-gu, South Korea, 03080